OpenAI is forecasting a major shift in the next five years around who it gets most of its computing power from, The ...

CompanyOverview|NASDAQ:RXRX] Recursion Pharmaceuticals' (NASDAQ: RXRX) stock price has seen a dramatic increase, not due to ...

If you are an investor that likes to do your own research, you can have your own cadre of AI agent co-pilots to support your investment decisions using GenAI models.

SoftBank's telco arm remains strong despite challenges, but high-risk AI ventures and premium valuations pose significant near-term investment risks. Learn more on SOBKY stock here.

Nvidia’s (NVDA) foray into investing in artificial intelligence startups seems to be showing yet more signs of success as one company it’s ...

This European AI stock seems well positioned to benefit from Trump's tariff threats. Also, see why DeepSeek Is ‘Good News' for European AI Companies.

An investor group is planning to build what's been billed as one of the world's largest AI data centers in South Korea at a ...

Shares of Recursion Pharmaceuticals closed 23.88% higher on Friday, marking their best single-day gain in nearly two years.

Billionaire Masayoshi Son, founder and CEO of Japanese multinational investment company SoftBank Group, is one of the richest people in the world. Considered one of the most powerful investors in the ...

The U.K.-headquartered chip design company Arm Holdings Plc. is reportedly planning to launch its first-ever complete ...

The UK-based chip designer pivots to selling its own chips, securing Meta as its first major customer, and challenging ...

While market sentiments among SoftBank investors remain pessimistic due to the emergence of more low-cost alternatives from ...